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Background/Aims: Cryotherapy is the therapeutic application for tissue ablation. Clinical applications of cryotherpy such as in pulm-
onology have increased. Until now, its development in gastroenterology has been insignificant. But, as clinical application such as muco-
sal ablation on Barrett’s esophagus became possible, various applications have been developed. Therefore, it is important to make stan-
dards of tissue injury’s extent in cryotherapy prior to clinical trial. We evaluated the tissue injury according to the application of 
cryoprobe with a pig model.
Methods: Cryoprobe was applied to several different segments of the esophagus and stomach for various lengths of time using various 
number of probe’s contact in a pig model. After 48 hours, esophagus and stomach were harvested and histological tissue injury was as-
sessed. The extent of tissue injury was decided by the injury of the deepest layer.
Results: Endoscopic application of cryoprobe on esophagus and stomach resulted in a dose-dependent injury: esophageal necrosis was 
limited to the submucosa after 10 seconds of cryotherapy, and extended to involve the transmural necrosis after over 15 seconds. Necro-
sis on stomach was extended to involve the transmural necrosis after over 20 seconds.
Conclusions: Positive relationship was seen between the duration and frequency of cryoprobe application and the extent of tissue injury.
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INTRODUCTION
Current mucosal ablation therapy, for endoscopic tumor 
removal or hemostasis, uses various devices, such as multipo-
lar electrocautery probes, argon plasma coagulator and heat 
probe.
1 Each of these devices, however, are limited by compli-
cations after therapy, incorrectness, or economic inefficiency, 
which is why there is a need for developing new devices for 
endoscopic therapy. Given that the cryotherapy has appeared 
as a useful alternative with favorable results for removing an 
endobronchial mass or a stricture by malignant, which were 
considered untreatable in the respiratory system, it may be 
considered in the digestive system too. Cryotherapy is to uti-
lize the primary injury when the tissue is rapidly frozen with 
low temperature and the secondary injury while the tissue is 
recovering. This method is being used in various fields and is 
expected to be more widely used in the future. Historically, 
there were reports that the cryotherapy has been used to treat 
wounds by infection from before christ and records that Hip-
pocrates performed cryotherapy for edema and pain due to 
trauma.
2 Modern cryotherapy was developed in 1961 by Coo-
per et al.
3 who designed a cryoprobe that is applicable clini-
cally to perform focal freezing to induce tissue necrosis. This 
method has been used, since then, for treatment of lesions in 
various organs, such as for removing an endobronchial mass 
and biopsy or for resecting a prostate cancer. Although not 
much in use in the digestive system, researchers are seeking 
ways to utilize this method in the digestive system, including 
the endoscopic treatment of Barrett’s esophagus
4 and bleeding 
mucosal vascular lesions.
5 The goal of cryotherapy is to lower 
the temperature in order to create complete necrosis of the 
target tissue with minimum injury on the surrounding tis-
sues.
6 It is crucial, therefore, to establish the standard of tissue 68  Clin Endosc 2012;45:67-72
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injury by cryotherapy, but there are little studies on the upper 
gastrointestinal cryotherapy in South Korea. The aim of this 
study was to assess the potential of cryotherapy by investigat-
ing the extent of tissue injury depending on the time and 
number of the applied cryoprobe in an animal test prior to a 
clinical application, and to further establish the standard of 
crytherapy.
MATERIALS AND METHODS
Cryoprobe
Among the 2 types of cryotherapy, which are cryospray and 
cryoprobe, we used a flexible cryo-probe, Erbokryo CA (Er-
bokryo; ERBE, Tübingen, Germany), which is used usually 
for biopsy and removal of endobronchial mass in the respira-
tory system, in this study. 
The underlying principle of the cryoprobe used in this 
study may be explained by the Joule-Thomson effect, where 
the temperature of the gas cools down when forced with a 
high pressure through a thin tube.
7 If the gas was N2O, the 
temperature of the escaped gas at the end of the probe would 
be -89°C theoretically.
8 We modified the length of the device 
from 0.9 to 1.5 m in order to improve the accessibility of the 
probe to the gastrointestinal tract, and did not observe the 
difference in the effectiveness depending on the length of the 
probe. Nitrous oxide was used as the refrigerant.
Subjects and endoscopic procedures
Four Yorkshire pigs were used in this study. Their mean age 
was 3±2 years and weights were around 20 kg. Endoscopy 
was performed under sedation to mark the sites where the 
cryoprobe should be applied in the esophagus and the stom-
ach using endoclips, and then the cryoprobe was applied 5, 
10, 15, 20, 30, or 60 seconds in the esophagus and 10, 20, 30, 
60, or 120 seconds in the stomach. Additional 10, 20, or 30 
seconds were applied nonconsecutively to differentiate the 
duration and number of probe application. Two-channel en-
doscopy was used for the accuracy of the manipulation time; 
saline solution was injected through the other channel when 
the applied probe has reached the scheduled time, to inter-
rupt the contact between the probe and the tissue and prevent 
freezing below the targeted temperature. The organs were 
harvested 48 hours after the intervention considering the in-
jury during the thawing (Fig. 1).
Histological study
The harvested esophagus and stomach were fixed for 48 
hours with 10% formalin solution, embedded in paraffin, sec-
tioned at about 5-µm, and stained using hematoxylin-eosin. 
Under the optical microscope, tissue injury was estimated by 
Fig. 1. Cryoablation of pig’s upper gastrointestinal tract. (A) Cryoablation by cryoprobe near endocliping site on esophagus. (B) Mucosal le-
sion after cryoablation on stomach. (C) Surgically resected esophagus after 48 hours. (D) Surgically resected stomach after 48 hours.
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the extent of tissue necrosis, based on the results that estimat-
ing the degree of injury across the tissue layers is clinically 
more meaningful than simply measuring the depth of inju-
ry.
9,10 Table 1 shows the grade of injury according to the trans-
mural extent of necrosis. Histopathologic findings were deter-
mined by clinic pathologists.
Approval of the study
This study was reviewed and approved by the Institutional 
Animal Care & Use Committee in Korea University. 
RESULTS
Results depending on the time of cryoprobing  
in the esophagus and the stomach 
In esophageal cryoatherapy, tissue necrosis was limited to 
the mucosa after 5 seconds of cryoablation, extended to in-
volve the submucosa after 10 seconds, involved part of the 
Table 1. Grade according to Transmural Extent of Necrosis
Grade Transmural extent of necrosis
Grade 0 No necrosis
Grade 1 Necrosis involving mucosa only
Grade 2 Necrosis involving submucosa
Grade 3 Necrosis involving muscularis propria
Grade 4 Transmural necrosis
Table 2. Effect of Varying Duration of Cryoprobing on Esophagus
Extent of injury
Duration of time, sec
5 10 15 20 30 60
Grade 1 ++++
Grade 2 ++++ +++ ++
Grade 3 + ++ +++
Grade 4 + ++++
Values are presented as number of sites of cryotherapy application. 
Grade 0, no necrosis; Grade 1, necrosis involving mucosa only; Grade 2, necrosis involving submucosa; Grade 3, necrosis involving muscula-
ris propria; Grade 4, transmural necrosis.
Fig. 2. Histopathologic findings of various durations of esophageal cryotherapy (H&E stain, ×100). (A) Cryoablation for 10 seconds, necro-
sis involving the layers of mucosa and submucosa but not muscularis propria. (B) Cryoablation for 15 seconds, attenuated surface epitheli-
um, necrotic lamina propria and muscularis mucosa and inflammatory extension to focal muscularis propria. (C) Cryoablation for 20 sec-
onds, necrosis and inflammatory reaction involving the submucosa and extension to the muscularis propria. (D) Cryoablation for 30 
seconds, necrosis and edema involving the layers of submucosa and the mucularis propria.
A  
C
B
D70  Clin Endosc 2012;45:67-72
Cryoprobe for Tissue Ablation
muscularis propria after 15 or 20 seconds with transmural 
necrosis after more than 30 seconds (Table 2, Fig. 2). In gas-
tric cryotherapy, tissue necrosis was limited to the mucosa af-
ter 10 seconds, extended to involve the submucosa after 20 se-
conds, and involved part of the muscularis propria after 30 
seconds with transmural necrosis after more than 60 seconds 
(Table 3, Fig. 3). There was a positive relationship between the 
duration of cryoablation and the extent of tissue damage based 
on the chart results (Figs. 4, 5).
Results depending on consecutive or  
nonconsecutive cryoablation
For cryoablation on the gastric tissues, the necrosis was 
confined to the mucosa when applied for 10 seconds consec-
utively, while the necrosis involved part of the submucosa 
when applied twice for 5 seconds separately; the necrosis was 
confined to the submucosa when applied for 20 seconds con-
secutively, while the necrosis involved part of the muscularis 
propria when applied twice for 10 seconds separately; finally, 
the necrosis involved the submucosa and part of the muscula-
ris propria both when applied for 30 seconds consecutively 
and when applied twice for 15 seconds separately, while the 
damage on the muscularis propria was more severe for the 
latter (Table 3, Fig. 3).
Table 3. Effect of Varying Duration of Cryoprobing on Stomach
Extent of injury
Duration of time, sec
10 5, twice 20 10, twice 30 15, twice 60 120
Grade 1 ++++ +++
Grade 2 + ++++ +++ ++ +
Grade 3 + ++ +++ ++++ +++
Grade 4 +
Values are presented as number of sites of cryotherapy application. 
Grade 0, no necrosis; Grade 1, necrosis involving mucosa only; Grade 2, necrosis involving submucosa; Grade 3, necrosis involving muscula-
ris propria; Grade 4, transmural necrosis.
Fig. 3. Histopathologic findings of various durations of gastric cryotherapy (H&E stain, ×100). (A) Cryoablation for 10 seconds, loss of up-
per part of mucosa and focal necrosis in the deeper part of mucosa, but not in other layers. (B) Cryoablation for 20 seconds, necrosis and 
inflammatory reaction in the submucosal layer. (C) Cryoablation for 10 seconds twice, loss and necrosis involving the layers of mucosa and 
submucosa and slight extension to superfical part of muscularis propria. (D) Cryoablation for 60 seconds, necrosis in the submucosal layer 
and extension to muscularis propria.
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DISCUSSION
Cryotherapy is widely accepted in various fields for being 
economically useful, easy to perform, and inducing few com-
plications. The purposes of this study were to determine the 
extent of tissue damage by cryoablation, to compare the ex-
tents of damage when the cryoprobe was applied consecu-
tively and nonconsecutively, and to establish an indicator for 
clinical use of the cryotherapy. We confirmed from the results 
that endoscopic cryotherapy using cryoprobe was applicable 
to both the stomach and esophagus and that the extent of tis-
sue injury was dose dependent.
The principle of tissue necrosis by cryotherapy may be ex-
plained by the freeze-thaw cycle mechanism, where extracel-
lular ice crystalization by freezing induces direct physical in-
jury to the cell membrane and indirectly causes crystalization 
within the cell, and then, during the course of thawing, the 
melted extracellular fluid flows through the damaged cell 
membrane into the cell to cause edema, the secondary dam-
age.
11 Especially when the cryotherapy is applied to tumors, it 
causes repeated constriction and dilation of blood vessels in 
tumor by repeated sudden freezing and thawing of the tumor 
tissue, which may reduce the blood flow rate, elicit micro-
thrombi, and finally an ischemic injury, leading to size reduc-
tion of the tumor tissue.
12
We could find that less tissue was injured when the cryo-
probe was applied for a shorter length of time compared to 
when the cryoprobe was applied for a longer length of time, 
based on the histopathology 48 hours after the cryoablation. 
Cryoablation for 10 seconds or less induced necrosis as far as 
the submucosa in the esophagus, while cryoablation for 20 
seconds or less induced necrosis as such in the stomach. 
There was a positive relationship between the duration of ex-
posure to the cryoprobe and the extent of tissue injury both 
in the stomach and esophagus.
Furthermore, when the cryoablation was performed in the 
stomach nonconsecutively in split-half dose, the extent of tis-
sue injury was similar to that of the consecutive cryoablation 
but the severity of the injury was more severe in the noncon-
secutive strategy, indicating that the grade of tissue necrosis is 
associated with the duration and number of cryoablation and 
that consecutive application induced less extent of injury than 
nonconsecutive application when the total length of time was 
the same. Raju et al.
9 studied the relationship between the tis-
sue injury and the duration of cryotherapy in the esophagus 
and revealed positive relationship. Unlike the fact that they 
used cryospray for the study, we used cryoprobe in this study 
and also extended the previous study by assessing the associa-
tion between the duration of cryoablation and tissue injury in 
the stomach as well as in the esophagus, with consistent re-
sults from both. We also compared the extent of tissue injury 
when the cryoablation was applied consecutively and non-
consecutively and found that the degree of injury was less in 
the consecutive strategy. This may be explained by that the ice 
crystals generated inside a cell gets bigger during the second 
freezing cycle and induce greater injury even when the total 
length of time was the same,
11,13 or that nonconsecutive repe-
Fig. 4. Effect of increasing duration of esophageal cryotherapy on 
the transmural extent of necrosis. Grade 0, no necrosis; Grade 1, 
necrosis involving mucosa only; Grade 2, necrosis involving sub-
mucosa; Grade 3, necrosis involving muscularis propria; Grade 4, 
transmural necrosis.
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Fig. 5. Effect of increasing duration of gastric cryotherapy on the 
transmural extent of necrosis. Grade 0, no necrosis; Grade 1, ne-
crosis involving mucosa only; Grade 2, necrosis involving submu-
cosa; Grade 3, necrosis involving muscularis propria; Grade 4, 
transmural necrosis.
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tition of the primary injury and the secondary injury might 
have been accumulated to cause greater damage.
Endoscopic cryotherapy is being used in various fields in-
cluding respiratory and urinary fields because it is simple, 
cheap, resolves strictures rapidly and effectively with mini-
mum risk of bleeding complication and adverse events. There 
are several limitations, yet, to clinical application of cryoprobe 
in the upper gastrointestinal area. First of all, the pressure of 
cryoprobe against a tissue may differ by operators and there-
fore the extent of tissue necrosis may be variable. Second, cr-
yoprobe is applicable only to focal lesions. Cryoprobe induces 
little injury to the neighboring normal tissues, which is an ad-
vantage when treating small lesions but a limitation for bigger 
lesions. Third, freezing effect might have been reduced by ex-
tending the length of the probe. We extended the length of 
the flexible probe from conventional 0.9 to 1.5 m and could 
not find reduced freezing effect; still, the possibility may not 
be excluded if the probe was extended longer than that. Final-
ly, the result that cryoprobe as applicable for only 10 seconds 
or less in the esophagus may suggest that it may be limited 
when using in organs with thin mucosa, such as the esopha-
gus or colon. Provided that these limitations were resolved, 
cryoprobe may be clinically applicable for treatment of upper 
gastrointestinal occlusion due to intrastent ingrowth of be-
nign lesion after catheterization through pyloric stenosis sec-
ondary to peptic ulcer. Based on the theory that malignant 
tumor cells are more easily affected by cryotherapy,
14 it may 
be also considered for treatment of stricture in the upper gas-
trointestinal tract due to intrastent tumor ingrowth. It may be 
also expected to reduce rebleeding after treatment of acute 
bleeding in patients with hematologic disorder, because it has 
rapid hemostasis effect and causes few bleeding complica-
tion.
15 Further, combination with other modalities such as la-
ser therapy or argon plasma coagulation is worth considering 
to supplement limitations of each devices.
In conclusion, with few studies on standard for clinical ap-
plication of endoscopic cryoprobe in the upper gastrointesti-
nal tract in South Korea, we investigated the association be-
tween the endoscopic application of cryoprobe and tissue 
injury in the esophagus and the stomach. Our results con-
firmed the positive relationship between the length of time 
the cryotherapy was applied and the extent of tissue injury, 
consistent with the previous studies, and more severe tissue 
injury when cryotherapy was performed nonconsecutively. 
Combining the above mentioned advantages of endoscopic 
cryotherapy and the results of this study, endoscopic cryo-
therapy may be considered as an alternative to tissue excision. 
Further comparative studies and data collection by animal 
and clinical tests with larger samples as well as technical de-
velopments in devices that could overcome the limitations of 
currently available cryoprobes are required for clinical appli-
cation of the cryoprobe. These are prerequisites to expand the 
application of the cryoprobe in gastrointestinal field.
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